David Mountcastle Sells 5,566 Shares of Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 5,566 shares of the business’s stock in a transaction dated Thursday, April 2nd. The stock was sold at an average price of $20.85, for a total transaction of $116,051.10. Following the completion of the sale, the chief financial officer owned 214,847 shares in the company, valued at approximately $4,479,559.95. This trade represents a 2.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

David Mountcastle also recently made the following trade(s):

• On Monday, March 16th, David Mountcastle sold 6,391 shares of Privia Health Group stock. The shares were sold at an average price of $22.11, for a total transaction of $141,305.01.
• On Friday, March 13th, David Mountcastle sold 6,565 shares of Privia Health Group stock. The shares were sold at an average price of $21.52, for a total transaction of $141,278.80.
• On Thursday, March 12th, David Mountcastle sold 6,453 shares of Privia Health Group stock. The stock was sold at an average price of $21.90, for a total value of $141,320.70.
• On Monday, March 9th, David Mountcastle sold 5,829 shares of Privia Health Group stock. The stock was sold at an average price of $22.84, for a total value of $133,134.36.
• On Friday, March 6th, David Mountcastle sold 5,177 shares of Privia Health Group stock. The shares were sold at an average price of $23.15, for a total value of $119,847.55.
• On Thursday, February 26th, David Mountcastle sold 5,361 shares of Privia Health Group stock. The shares were sold at an average price of $25.00, for a total value of $134,025.00.
• On Friday, February 27th, David Mountcastle sold 7,697 shares of Privia Health Group stock. The shares were sold at an average price of $25.05, for a total value of $192,809.85.

Privia Health Group Price Performance

Shares of Privia Health Group stock traded up $0.38 on Monday, reaching $21.59. The company had a trading volume of 900,724 shares, compared to its average volume of 818,323. The firm has a market cap of $2.67 billion, a price-to-earnings ratio of 127.00, a P/E/G ratio of 1.32 and a beta of 0.87. The firm’s 50-day moving average price is $22.14 and its two-hundred day moving average price is $23.43. Privia Health Group, Inc. has a 1 year low of $18.77 and a 1 year high of $26.51.

Privia Health Group (NASDAQ:PRVA) last released its quarterly earnings results on Thursday, February 26th. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.21. The company had revenue of $541.17 million for the quarter, compared to analyst estimates of $516.61 million. Privia Health Group had a return on equity of 3.06% and a net margin of 1.08%.Privia Health Group’s quarterly revenue was up 17.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.21 EPS. As a group, analysts anticipate that Privia Health Group, Inc. will post 0.14 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on PRVA. Barclays raised their target price on shares of Privia Health Group from $23.00 to $25.00 and gave the stock an “equal weight” rating in a report on Wednesday, March 25th. Royal Bank Of Canada started coverage on shares of Privia Health Group in a report on Friday, January 9th. They set an “outperform” rating and a $31.00 price target on the stock. Truist Financial raised their price objective on shares of Privia Health Group from $31.00 to $33.00 and gave the stock a “buy” rating in a research note on Monday, March 2nd. Jefferies Financial Group restated a “buy” rating and set a $32.00 target price on shares of Privia Health Group in a research report on Thursday, February 26th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Privia Health Group in a research note on Friday, March 27th. Thirteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, Privia Health Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $31.13.

Institutional Trading of Privia Health Group

Institutional investors and hedge funds have recently made changes to their positions in the business. Bayban purchased a new stake in shares of Privia Health Group during the fourth quarter valued at $26,000. Hantz Financial Services Inc. increased its stake in Privia Health Group by 456.2% in the 4th quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock worth $27,000 after buying an additional 926 shares during the period. Global Retirement Partners LLC lifted its holdings in Privia Health Group by 579.8% during the 4th quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock valued at $38,000 after buying an additional 1,351 shares in the last quarter. Canada Pension Plan Investment Board lifted its holdings in Privia Health Group by 48.0% during the 2nd quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock valued at $85,000 after buying an additional 1,200 shares in the last quarter. Finally, Kestra Advisory Services LLC purchased a new stake in Privia Health Group in the 4th quarter valued at about $93,000. 94.48% of the stock is currently owned by institutional investors.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.